Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 276 No 7390 p257
4 March 2006

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Warning over vaccine-related events during pandemic preparations

A cautionary tale from the Centres for Disease Control, Atlanta, Georgia, on mass vaccination could lead governments and national media to temper their enthusiasm for vaccination as the major way that any influenza pandemic is ultimately controlled.

John Iskander, project officer for CDC’s vaccine adverse events reporting system, was involved in the 1976 US swine flu vaccine programme that prepared for “a pandemic that wasn’t” and instead — as an unintended consequence — produced a vaccine-related increase in Guillain-Barré syndrome. Dr Iskander told the Bird Flu Summit held in Washington, DC, earlier this week that the 1976 increase in Guillain-Barré syndrome (GBS) was a “classic rare but extremely serious event”. The vaccines were associated with a GBS increase of one case per 100,000 vaccinated.

The disease requires admission to hospital, intensive care and ventilator use, all resources that would be in short supply during an influenza pandemic, Dr Iskander noted.

Current studies are looking at the 1976 vaccines to see if they can determine what caused the increase in GBS. He added that the incidence of GBS has been declining and has not been associated with other vaccines.

Dr Iskander also commented that existing vaccine tracking programmes may have to be enhanced during an influenza pandemic to include more data to pick up possible adverse events more effectively. One option being considered is bar-coding vaccines and linking them to patient records.

Back to Top


©The Pharmaceutical Journal